In 2015, Sara Nowinski, PhD received a $70,000 grant award for her work “Characterizing the Function of the Atypical Mitochondrial Kinase...
Read: Research Update from 2015 UMDF Grant Recipient Sara Nowinski, PhDOn Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – February 2023: Could ARPA-H Change the Research Landscape for Rare Diseases?On Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – January 2023: What Does 2023 Hold for Mito Advocacy?On Tuesday, December 20, 2022, lawmakers unveiled their long-awaited $1.7 trillion government funding package. The package includes 12...
Read: Advocacy Update – December 2022: Mito Research Funding Looks Headed for Renewal in Newly Unveiled Funding BillResearch Update At the very first The Big Pitch Event at the UMDF Symposium for Mitochondrial Medicine in 2019, three candidates had five...
Read: accelerators Research Update from Rachel Guerra, PhD, UMDF Funded Runner-Up from Big Pitch 2019This week, as part of World Mitochondrial Disease Week, UMDF President & CEO Brian Harman caught up with the offices of several members of...
Read: Advocacy Update – September 2022: Three Things You Should Ask of Congress as We Wrap Up World Mitochondrial Disease WeekThis week, as part of World Mitochondrial Disease Week, UMDF President & CEO Brian Harman caught up with the offices of several members of...
Read: UMDF Marks World Mitochondrial Disease Week, September 18 – 24, 2022This Tuesday, September 13 is TK2d Tuesday, a day to bring awareness to a rare genetic mitochondrial disease, Thymidine kinase 2 deficiency....
Read: UMDF Brings Awareness, Support for Patients and Families on TK2d Tuesday — Sept. 13, 2022(Pittsburgh, PA – July 20, 2022) The United Mitochondrial Disease Foundation (UMDF) today announced Alicia M. Palladino, JD, PhD, an...
Read: Alicia Palladino Named Board Chair for The United Mitochondrial Disease FoundationCyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...
Read: Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by UMDF